Evidence map›Paper›PMID 20924638›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2011

E. coli lipopolysaccharide attenuates adenosine A(1) receptor-mediated increase in plasma exudation from the hamster cheek pouch.

Xiao-pei Gao, Israel Rubinstein

Abstract read
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Xiao-pei GaoDepartment of Medicine (M/C 719), College of Medicine, University of Illinois at Chicago, 840 South Wood Street, Chicago, IL 60612-4325, USA.
Israel Rubinstein
Jesse Brown VA Medical Center · USUniversity of Illinois Chicago · US

Funding

Micellar VIP Nanoparticles for Rheumatoid ArthritisR01AG024026 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RUBINSTEIN, ISRAEL · 2004 to 2007
$1.1M
NHLBI NIH HHS R01 HL72343NIA NIH HHS R01 AG024026
6 · The paper itself

Abstract

OBJECTIVE AND

designTo determine whether exposure to E. coli lipopolysaccharide (LPS) modulates adenosine A(1) receptor-induced increase in plasma exudation from the intact hamster cheek pouch microcirculation. METHODS AND

resultsUsing intravital microscopy, we found that suffusion of R(-)-N(6)-(2-phenylisopropyl)-adenosine (R(-)-PIA) (1.0 and 10.0 nM), a selective adenosine A(1) receptor agonist, onto the intact cheek pouch elicited significant, concentration-dependent leaky site formation and increase in clearance of fluorescein thioisocyanate-dextran (mol mass, 70 kDa) from post-capillary venules (p < 0.05). These responses were significantly attenuated by pre-treatment of hamsters with LPS (p < 0.05). By contrast, LPS had no significant effects on CGS-21680-, a selective adenosine A(2A) receptor agonist, bradykinin- and substance P-induced increases in plasma exudation from the cheek pouch.

conclusionThese data indicate that LPS attenuates adenosine A(1) receptor-induced increase in plasma exudation in vivo in a specific fashion. We suggest that this phenomenon represents an endogenous anti-inflammatory cue to avoid excessive inflammation during Gram-negative bacterial infections.

Indexed as

AnimalsBradykininCheekCricetinaeEscherichia coliLipopolysaccharidesMesocricetusMicrocirculationPlasmaReceptor, Adenosine A1Substance PBradykininLipopolysaccharidesReceptor, Adenosine A1Substance P

Identifiers

PMID20924638
PMCPMC3698484
OpenAlexW2005453298

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.